Entactbio
Watertown, US · Founded 2021 · 2 known investors
Entact is a drug discovery company developing treatments for patients. It works in the biotechnology and therapeutics sector.
Founders & leadership
VR
Victoria RichonExecutive
RT
Ruben TommasiChief Scientific Officer
MG
Michael GutchChief Operating Officer
AL
Alon LazarusNamed on SEC filing
Board
AS
Andrew SinclairBoard director
AF
Anna FrenchBoard director
PO
Pini OrbachBoard director
RG
Richard GasterBoard director
OS
Owen SmithBoard director
Investors · 2
Reported raises · per SEC filings
Form D private placements$50.3M disclosed across 2 rounds · 2024–2026
▶$10MraisedJun 2026 · 7 investors · BiotechnologyRule 506(b)
▶$10MraisedJun 2026 · 7 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Andrew SinclairDirector
- Anna FrenchDirector
- Pini OrbachDirector
- Victoria RichonExecutive Officer, Director, Promoter
- Richard GasterDirector
- Owen SmithDirector
- Offering amount
- $10M
- Amount sold
- $10M
- First sale
- Jan 2026
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
▶$40.3MraisedMay 2024 · 7 investors · BiotechnologyRule 506(b)
▶$40.3MraisedMay 2024 · 7 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Victoria RichonExecutive Officer, Director
- Owen SmithDirector
- Anna FrenchDirector
- Richard GasterDirector
- Alon LazarusDirector
- Andrew SinclairDirector
- Offering amount
- $40.3M
- Amount sold
- $40.3M
- First sale
- Jan 2024
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 4
by search overlap
Encapsulate6 shared keywordsEncapsulate builds automated tumor-on-a-chip systems that test microtumors derived from patient biopsies against treatment regimens to predict how individual cancer patients will respond, delivering personalized insights in under seven days. It serves oncologists, pharmaceutical companies, and cancer researchers, drawing on a patient biobank for drug testing, patient stratification, and mechanism studies.
Engage Bio6 shared keywordsEngageBio develops DNA-based medicines using proprietary non-viral delivery technology to achieve extended therapeutic expression from a single dose with low manufacturing complexity.
Inceptor Bio5 shared keywordsInceptor Bio is a clinical-stage biotechnology company developing cell therapies for cancer, focused on solid tumors. Its OUTLAST platform reprograms T cells during manufacturing to withstand the tumor microenvironment, and its lead candidate is IB-T101.
Arsenal Biosciences5 shared keywordsArsenal Biosciences is a clinical-stage company developing programmable cell therapies to treat solid tumors. The company uses computational and engineering approaches to create cancer medicines.
Companies competing with Entactbio for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Entactbio do?
- Entact is a drug discovery company developing treatments for patients. It works in the biotechnology and therapeutics sector.
- Who are Entactbio's investors?
- Entactbio's investors include venBio Partners, venBio Global Strategic.
- How much funding has Entactbio raised?
- Entactbio has disclosed $50.3M raised across 2 rounds.
- Where is Entactbio headquartered?
- Entactbio is headquartered in Watertown, US.